SynthesisCritical reviews in oncology/hematology2020
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.
Synthesis in Critical reviews in oncology/hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
121 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- Pooled it
- The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review.Seminars in oncology · 2022Pooled it
- Nanogels as target drug delivery systems in cancer therapy: A review of the last decade.Frontiers in pharmacology · 2022Pooled it
- Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.Oncoimmunology · 2020Pooled it
- Which type of cancer patients are more susceptible to the SARS-COX-2: Evidence from a meta-analysis and bioinformatics analysis.Critical reviews in oncology/hematology · 2020Pooled it
- Managing cancer care during the COVID-19 pandemic: brief report from a North African single center.The Pan African medical journal · 2020Pooled it
- Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review.Diabetes & metabolic syndromePooled it
- The Hidden Cost of Delay: Post-Pandemic Evolution of Advanced Ovarian Cancer Profiles.Medicina (Kaunas, Lithuania) · 2026Article
- Review
- Integration of multi-omics approaches in exploring intra-tumoral heterogeneity.Cancer cell international · 2025Review
- Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021.Biomarker research · 2025Article
- COVID-19 and cancer: reflections 2 years into the pandemic.Korean journal of clinical oncology · 2024Article
- Article
- Prognostic model for gastric cancer patients with COVID-19 and network pharmacology study on treatment by lentinan.Scientific reports · 2024Article
- Effect of aberrant fructose metabolism following SARS-CoV-2 infection on colorectal cancer patients' poor prognosis.PLoS computational biology · 2024Article
- Trends analysis of cancer incidence, mortality, and survival for the elderly in the United States, 1975-2020.Cancer medicine · 2024Article
- A Retrospective Analysis of Azvudine in Patients with COVID-19 and Pre-existing Cancer.Journal of Cancer · 2024Article
- Patient Adherence to Oral Anticancer Agents: A Mapping Review of Supportive Interventions.Current oncology (Toronto, Ont.) · 2023Review
- A polyoxomolybdate-based hybrid nano capsule as an antineoplastic agent.Nanoscale advances · 2023Article
- Challenges of Integrated Home-Based Palliative Care Services for Cancer Patients during the COVID-19 Pandemic: A Qualitative Content Analysis.Home health care management & practice · 2023Article
61 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 complications. This observation led many oncologists to change their daily practice in cancer care, without solid evidence and recommendations. Moreover, the COVID-19 manifestations as well as its diagnosis are particular in this special population. In this review paper we expose the challenges of cancer management in the era of SARS-CoV-2, the epidemiological, clinical, pathological and radiological characteristics of the disease in cancer patients and its outcomes on this population. Finally, we focus on strategies that are followed in cancer management with review of national and international guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.